Dr. In Ah Kim is a professor of Department of Radiation Oncology at Seoul National University College of Medicine in South Korea. She is a board-certified radiation oncologist focuses primarily on breast cancers and brain tumors. Over her career, she has led multiple basic, translational research projects, and multi-institutional clinical trials, including collaborative study of NRG Oncology and Korean Radiation Oncology Group.
Academic and leadership roles
She served as the president of the Korean Society of Radiation Bioscience, the vice-president of Korean Society for Radiation Oncology, the chair of the Brain Tumor Committee & Translational Research Committee of the KROG (Korean Radiation Oncology Group) and Metastatic Brain Tumor Committee of the KNOG (Korean Neuro-Oncology Group). She has also served on the boards of the Korean Breast Cancer Society, and Korean Society of Neuro-Oncology. She currently serves as a standing board member of the Korean Cancer Association, a councilor of the National Academy of Medicine of Korea, and an expert advisor to Korea’s National Research Foundation and the Ministry of Science and ICT Nuclear R&D committee.
Research
Dr. Kim has been leading several clinical trials in the areas of breast cancer and malignant brain tumors including the now-completed NRG Oncology/RTOG1119 trial. She has also been leading multiple basic and translational research projects mainly focused on the preclinical studies on modulating radiation response by targeting pro-survival signaling and immunosuppressive cells. She is also currently focusing on immunogenomic studies using patient-derived biospecimens. Dr. Kim has authored or co-authored more than 250 peer-reviewed publications.
Disclosures:
- Employment: none
- Compensation: :Role Topic Description-End Date:
- Ownership: none
- Leadership: none